You just read:

Daiichi Sankyo Presents Updated Results of [Fam-] Trastuzumab Deruxtecan (DS-8201) in Patients with HER2 Expressing Advanced Colorectal Cancer at 2018 European Society for Medical Oncology (ESMO) Congress

News provided by

Daiichi Sankyo Company, Limited

21 Oct, 2018, 11:45 BST